IntegraMed Featured at The Wall Street Analyst Forum - November 5, 2001.

PURCHASE, N.Y., Oct. 22 /PRNewswire/ --

IntegraMed America, Inc. (Nasdaq: INMD) today announced participation in the Wall Street Analyst Forum's Institutional Investor Conference to be held in New York City on November 5, 2001 at 8:45 AM. The presentation to analysts and portfolio managers will focus on Company strategy, product and service offerings and growth plans. Approximately 100 public companies will be featured during this three-day conference.

Analysts and portfolio managers who wish to attend the presentation should contact The Wall Street Analyst Forum at 802-253-7596 to request additional information.

Investors may access an Internet webcast of the presentation at: http://media.corporate-ir.net/media_files/priv/WSAF/schedule/100501.htm.

IntegraMed, based in Purchase, NY offers products and services to patients, providers, payers and manufacturers focused on the $2 billion infertility industry. Specifically, the Company provides Business Services to a network of Fertility Centers; distributes pharmaceutical products and financing programs directly to patients and, conducts clinical research through IntegraMed Research Institute.

Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed America are forward-looking statements. Actual results may differ materially from the statements made as a result of various factors including, but not limited to, the risks associated with the Company's ability to finance future growth; the loss of significant management contract(s); profitability at Reproductive Science Centers managed by IntegraMed America; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; risks associated with the year 2000 and other risks, including those identified in the Company's most recent Form 10-K and in other documents filed by the Company with the U.S. Securities and Exchange Commission (SEC).

MAKE YOUR OPINION COUNT - Click Here

http://tbutton.prnewswire.com/prn/11690X27427126